BACKGROUND: EMR is commonly performed before radiofrequency ablation (RFA) for
nodular dysplastic Barrett's esophagus (BE). OBJECTIVE: To determine the efficacy and …

The effects of preceding endoscopic mucosal resection (EMR) on the efficacy and safety of
radiofrequency ablation (RFA) for treatment of nodular Barrett's esophagus (BE) is poorly …

BACKGROUND:: Radiofrequency ablation (RFA) is safe and effective for eradicating
Barrett's esophagus (BE) and BE-associated early neoplasia. Most RFA studies have limited …

BACKGROUND & AIMS: The goal of radiofrequency ablation (RFA) for patients with Barrett's
esophagus (BE) is to eliminate dysplasia and metaplasia. The efficacy and safety of RFA for …

Background: After endoscopic resection (ER) of high-grade dysplasia (HGD) and early
cancer (EC) in Barrett esophagus (BE), the residual BE remains at risk for neoplasia …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) is safe and effective for eradicating
intestinal metaplasia and neoplasia in patients with Barrett's esophagus. We sought to …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) is safe and effective treatment for
flat dysplasia associated with Barrett's esophagus (BE). However, there are limited data on …

Abstract Background Although Endoscopic Submucosal Dissection (ESD) was proven
superior to Endoscopic Mucosal Resection (EMR) in achieving higher complete remission …

The current standard of treating early Barrett's neoplasia is resection of visible lesions using
endoscopic mucosal resection (EMR) followed by ablative therapy to the Barrett's segment …

Background and study aim: Endoscopic resection with radiofrequency ablation (RFA) 6
weeks later safely and effectively eradicates Barrett's esophagus with high grade dysplasia …